DrugCard

DrugCard is a specialized AI-enabled data intelligence platform that revolutionizes pharmacovigilance by automating and streamlining drug safety routines. In an industry facing increasing regulatory pressure, rising costs, and the complexities of global markets, DrugCard offers a robust solution to manage local medical literature screening (MLM). The platform is engineered to replace the traditional, time-consuming manual process of reviewing journals, thereby significantly reducing human error and boosting operational efficiency by up to 70%.

The core mission of DrugCard is to provide a continuous, traceable, transparent, and accurate system for monitoring medical literature. It covers an extensive network of over 1500 local journals across more than 83 countries and supports over 100 languages. This vast coverage ensures that Marketing Authorization Holders (MAHs) and Contract Research Organizations (CROs) can maintain comprehensive oversight and full compliance with global and local regulatory requirements, no matter where they operate.

How to use DrugCard

Using DrugCard is a straightforward process designed for seamless integration into existing pharmacovigilance workflows:

1. Initial Consultation & Setup: Begin by scheduling a demo or meeting with the DrugCard team. During this phase, you will define the scope of your screening needs, including specific drugs, countries, and a list of local medical journals to be monitored.
2. Automated AI Screening: Once configured, the DrugCard platform takes over. Its AI engine continuously and automatically scans the specified journals. The system uses advanced Natural Language Processing (NLP) and Optical Character Recognition (OCR) to analyze content, even from poorly scanned texts, to identify potential Individual Case Safety Reports (ICSRs) and other relevant safety information.
3. Data Review and Analysis: The platform flags all relevant findings, such as mentions of your products in conjunction with adverse events. The results are presented in a structured and easily accessible format, allowing your PV team to quickly review and assess the information.
4. Reporting and Auditing: DrugCard generates regular, comprehensive reports (e.g., weekly summaries) that consolidate all collected data. The entire process is fully traceable and transparent, creating a clear audit trail that is essential for regulatory inspections. This ensures you can demonstrate compliance at any time.

Core Features of DrugCard

• AI-Powered Automation: Leverages artificial intelligence to automate the screening of local medical literature, saving significant time and resources compared to manual methods.
• Extensive Global Coverage: Monitors over 1500 local medical journals in more than 83 countries, providing comprehensive global reach.
• Multi-Language Support: Supports over 100 languages, breaking down language barriers in global pharmacovigilance.
• Advanced OCR Technology: Capable of accurately recognizing and processing text from scanned documents, ensuring no data is missed due to poor image quality.
• Traceability and Transparency: Provides a complete and auditable trail of all screening activities, ensuring full compliance with regulatory standards like GVP.
• Scalability: Easily scales to include new markets, products, or journals, allowing your operations to grow without a proportional increase in manual workload.
• Cost-Effective Solution: Offers a CAPEX-free investment model, providing a high return on investment by reducing labor costs and improving efficiency.

Use Cases for DrugCard

DrugCard is designed for various stakeholders within the pharmaceutical industry:

• Contract Research Organizations (CROs): CROs can manage more pharmacovigilance projects simultaneously and deliver superior screening results to their pharma clients. The platform enhances their service offering, ensuring clients are fully compliant and satisfied.
• Marketing Authorization Holders (MAHs): MAHs can ensure continuous regulatory compliance across all markets where their products are sold. DrugCard helps them proactively identify adverse reactions and manage drug safety with a holistic, global view.
• Pharmacovigilance Freelancers: Individual PV professionals can leverage DrugCard to automate the laborious task of literature screening, freeing up time to focus on higher-value analysis and take on more clients.
• Market Expansion: Companies entering new countries can quickly and cost-effectively set up the required local literature monitoring processes, accelerating time-to-market.

Advantages of DrugCard

The primary advantage of DrugCard is its ability to transform a resource-intensive manual task into an efficient, automated process. This leads to significant time savings (up to 70%), reduced operational costs, and a lower risk of non-compliance. The platform's accuracy, scalability, and comprehensive coverage provide peace of mind and a competitive edge in a demanding regulatory landscape. By handling the complexities of multi-language and multi-region monitoring, DrugCard allows pharmacovigilance teams to focus on strategic safety analysis rather than manual data collection.

Pricing and Plans

DrugCard's pricing is tailored to the specific needs of each client. As an enterprise-level solution, it does not offer standard public pricing tiers. To get a quote, potential customers are encouraged to contact the sales team or schedule a demo to discuss their requirements, such as the number of products, countries, and journals to be monitored. This customized approach ensures that you only pay for the services you need.